NI
IRWD icon

Numeric Investors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Numeric Investors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-23,283
Closed -$298K – 1078
2016
Q4 		$298K Sell
23,283
-5,612
-19% -$70.9K ﹤0.01% 914
2016
Q3 		$384K Buy
+28,895
New +$338K ﹤0.01% 866
2015
Q3 		– Sell
-29,134
Closed -$294K – 1061
2015
Q2 		$294K Sell
29,134
-24,954
-46% -$290K ﹤0.01% 757
2015
Q1 		$725K Buy
+54,088
New +$710K 0.01% 552
2013
Q3 		– Sell
-31,184
Closed -$259K – 807
2013
Q2 		$259K Buy
+31,184
New +$378K 0.01% 689

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Numeric Investors's IRWD Position: Q1 2017 in Review

Numeric Investors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2017, closing a stake of 23,283 shares — an estimated $298K sold.

Numeric Investors first reported a position in IRWD in Q2 2013 and held it in 5 quarters. The position peaked at $725K in Q1 2015. 162 funds tracked by Wall St. Rank hold IRWD as of Q1 2017.

  • Numeric Investors reported no remaining Ironwood Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Numeric Investors sold 23,283 Ironwood Pharmaceuticals shares in Q1 2017, an estimated $298K.
  • Numeric Investors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Numeric Investors's Ironwood Pharmaceuticals position peaked at $725K in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2017.

Based on Numeric Investors's 13F filing for Q1 2017, filed 15 May 2017.